Summary of Study ST003159
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001964. The data can be accessed directly via it's Project DOI: 10.21228/M8VD96 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST003159 |
Study Title | Untargeted serum metabolomics in the Parkinson's Environment and Genes (PEG) Study |
Study Summary | This project aims to evaluate the serum metabolome of Parkinson’s disease (PD) patients relative to unaffected controls in the Parkinson’s Environment and Genes (PEG) Study. Background: Untargeted high-resolution metabolomic profiling provides simultaneous measurement of thousands of metabolites. Metabolic networks based on these data can help uncover disease-related perturbations across interconnected pathways. Objective: Identify metabolic disturbances associated with PD in the PEG population-based study using untargeted metabolomics. Methods: We provide serum-based untargeted metabolomics data derived from liquid chromatography with high-resolution mass spectrometry (LC-HRMS). LC-HRMS detected 4,762 metabolites for analysis (HILIC: 2716 metabolites; C18: 2046 metabolites). |
Institute | University of California, Los Angeles |
Department | Neurology |
Last Name | Paul |
First Name | Kimberly |
Address | 710 Westwood Plaza, Los Angeles, CA, 90095, USA |
kimberlp@ucla.edu | |
Phone | 310.206.7458 |
Submit Date | 2023-12-15 |
Total Subjects | 919 |
Analysis Type Detail | LC-MS |
Release Date | 2024-04-23 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Treatment:
Treatment ID: | TR003286 |
Treatment Summary: | Samples are from participants of the PEG study, which is a population-based Parkinson's disease case-control study from Central California |